Mark Edward Spring - 29 Jan 2026 Form 4 Insider Report for ARTELO BIOSCIENCES, INC. (ARTL)

Signature
/s/ Gregory D. Gorgas, as Attorney-in-Fact
Issuer symbol
ARTL
Transactions as of
29 Jan 2026
Net transactions value
$0
Form type
4
Filing time
02 Feb 2026, 16:38:04 UTC
Previous filing
17 Nov 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Spring Mark Edward Chief Financial Officer C/O ARTELO BIOSCIENCES, INC., 505 LOMAS SANTA FE, SUITE 160, SOLANA BEACH /s/ Gregory D. Gorgas, as Attorney-in-Fact 02 Feb 2026 0002091857

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARTL Stock Options (right to buy) Award $0 +36,391 $0.000000 36,391 29 Jan 2026 Common Stock 36,391 $1.68 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan) through each such applicable vesting date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date, such that the option shall be fully vested on the four (4) year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean January 1, 2026.